July 13, 2016
ARIAD Pharmaceuticals recently entered into a deal that gives Dubai-based Biologix FZCo. the rights to distribute blood cancer drug Iclusig throughout numerous countries in the Middle East and North Africa (MENA) region. Under the distribution deal with ARIAD, Biologix can commercialize the drug in Bahrain, Kuwait, Lebanon, Oman, Saudi Arabia, Qatar and United Arab Emirates.
Read more →
Sign-up for the Weekly Newsletter from Gulf News Journal.